Buradasınız

Diyabetik hastalarda deri belirtileri

Skin symptoms in patients with diabetes

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Diabetes mellitus is a worldwide public health problem which is a metabolic disorder affecting various organ systems including skin and characterized by high serum glucose levels. The metabolic complications and pathologic changes in diabetic patiens cause the occurrence of various dermatoses. More than 30% of diabetic patiens have any type of cutaneous involvement during the course of disease. Skin manifestations generally appear during the course of the disease in patients known to have diabetes, but they may also be the first presenting sign of diabetes. In this article, skin disorders due to diabetes mellitus were reviewed.
Abstract (Original Language): 
Diabetes mellitus, deriyi de içeren birçok organ sistemini etkileyen ve serum glukoz düzeyi yüksekliği ile karakterize bir metabolik hastalık olup tüm dünyada yaygın bir halk sağlığı problemidir. Diyabetik hastalarda metabolik komplikasyonlar ve patolojik değişiklikler çeşitli dermatozların görülmesine neden olmaktadır. Diyabetik hastaların %30’undan fazlasında hastalıkları süresince herhangi bir deri tutulumuna rastlanılır. Deri bulguları genellikle diyabeti olduğu bilinenlerde hastalığı süresince ortaya çıkmakla birlikte diyabetin ilk bulgusu olarak da görülebilirler. Bu makalede diyabete bağlı gelişen deri hastalıkları gözden geçirilmiştir.
43-47

REFERENCES

References: 

1. Ahmed I, Goldstein B. Diabetes mellitus. Clin
Dermatol 2006; 24;237-246.
2. Kalus AA, Chien AJ, Olerud JE. Diabetes Mellitus
and Other Endocrine Diseases. Fitzpartick’s
Dermatology in general medicine. Eds. Wolf K,
Goldsmith LA, Katz SI, Gılchrest BA, Paller AS,
Leffell DJ. 7. Baskı. Mc-Graw-Hill. 2008; 1461-1470.
3. İşçimen A, Arzuhal N. Diabetes mellituslu hastalarda
görülen deri belirtileri. Dermatose 2004; 3(1):18-25.
4. Hattem SV, Bootsma AH, Thio HB. Skin
manifestations of diabetes. Cleveland Clinic Journal
Of Medicine 2008; 75(11);772-787.
5. Saray Y, Özcan D, Seçkin D. Tip 2 Diabetes
mellituslu hastalarda deri bulguları. Türkiye Klinikleri
J Med Sci 2005; 25:377-382.
6. Gupta AK, Konnikov N, MacDonald P, Rich P,
Rodger NW, Edmonds MW, et al. Prevalence and
epidemiology of toenail onychomycosis in diabetic
subjects: a multicenter survey. Br J Dermatol 1998;
139:665–671.
7. Terzi E, Pekşari Y. Diabetes mellitusun deri bulguları
ve diabetik ayak. T Klin Dermatoloji 2003; 13:50-60.
8. Mayser P, Freund V, Budihardja D. Toenail
onychomycosis in diabetic patients: issues and
management. Am J Clin Dermatol 2009; 10(4):211-
220.
9. Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Heagerty
PJ. Prediction of diabetic foot ulcer occurrence using
commonly available clinical information: the Seattle
Diabetic Foot Study. Diabetes Care 2006; 29:1202-
1207.
10. Cathcart S, Cantrell W, Elewski BE. Onychomycosis
and Diabetes. JEADV 2009; 23:1119-1122.
11. Sarkany RPE, Breathnach SM, Seymour CA,
Weismann K, Burns DA. Metabolic and nutritional
disorders. Rook’s textbook of dermatology. Eds.
Burns T, Breathnach S, Cox N, Griffiths C. 7.Baskı.
Blackwell. 2004: 2847-2971.
12. Shinozaki S, Itabashi N, Rokkaku Ichiki K, Nagasaka
S, Okada K, Fujimoto M, et al. Diabetic lipemia with
eruptive xanthomatosis in a lean young female with
apolipoprotein E4/4. Diabetes Res Clin Pract 2005;
70(2):183-192.
13. Callen JP. Dermatologic Manifestations in Patiens
with Systemic Disease. Dermatology. Eds. Bolognia
JL, Jorizzo JL, Rapini RP. 2. Baskı. Elsevier. 2008:
675-692.
14. Morgan AJ, Schwartz RA. Diabetic dermopathy: A
subtle sign with grave implications. J Am Acad
Dermatol 2008; 58:447-451.
15. Karataş M, Karakuzu A. Endokrin sistem hastalıkları
ve deri. Dermatoloji. Ed. Tüzün Y, Gürer MA,
Serdaroğlu S, Oğuz O, Aksungur VL. 3.Baskı. İstanbul;
Nobel Tıp Kitabevleri; 2008; 1145-1149.
16. Ghosh SK, Bandyopadhyay D, Chatterjee. Bullosis
diabeticorum: A distinctive blistering eruption in
diabetes mellitus. Int J Diab Dev Ctries 2009;
29(1):41-42.
17. Lipsky BA, Baker PD, Ahroni JE. Diabetic Bullae: 12
cases of a purportedly rare cutaneous disorder. Int J
Dermatol 2000; 39:196-200.
18. Gruson LM, Franks A. Scleredema and diabetic
sclerodactyly. Dermatology Online Journal 2005;
11(4):3.
19. Namazi MR, Jorizzo JL, Fallahzadeh MK. Rubeosis
faciei diabeticorum: a common, but often unnoticed,
clinical manifestation of diabetes mellitus.
ScientificWorld Journal 2010; 10:70-71.
20. Singh N, Armstrong DG, Lipsky BA. Preventing foot
ulcers in patients with diabetes. JAMA 2005;
293(2):217-228.
21. Chen HF, Ho CA, Li CY. Age and sex may
significantly interact with diabetes on the risks of
lower-extremity amputation and peripheral
revascularization procedures: evidence from a cohort
of a half-million diabetic patients. Diabetes Care 2006;
29(11):2409-2414.
22. Eye M, Masson EA. Dermatological care of the
diabetic foot. Am J Clin Dermatol 2002; 3:463-467.
23. Körber A, Dissemond J. Necrobiosis lipoidica
diabeticorum. CMAJ 2007; 177(12);1498.
24. Higgins SP, Freemark M, Prose NS. Acanthosis
nigricans: Acanthosis nigricans: a practical approach
to evaluation and management. Dermatology Online
Journal 2008; 14(9):2.
25. Saray Y, Seçkin D, Bilezikçi B. Acquired perforating
dermatosis: clinicopathological features in twenty-two
cases. JEADV 2006; 20:679-688.
İletişim:
Uzm.Dr. Adem Parlak
Ağrı Asker Hastanesi, Aile Hekimliği Servisi
Ağrı, Türkiye
Tel: +90.532.7086899
e-mail: cipro0055@yahoo.com

Thank you for copying data from http://www.arastirmax.com